Among the 27 somatic mutations, 24 were restricted to the brain metastases, of which 4 affected cancer-related genes (i.e., FGFR2, MAP2K4, ATR and PIK3CA) (Figure 1C) [12–16]. The gene discussed is PIK3CA; the disease is cancer.